Career History

• Vertice Pharmaceuticals (2020-2022): Chief Financial Officer
• Successfully assisted in first branded product launch and subsequent sale of the company maximizing investor value
• Amneal Pharmaceuticals (2009-2020) : Various senior executive positions within finance team
• Played key role in driving strategic initiatives to build the business from start up to $1.5 billion in revenue, including managing treasury, debt, risk management, financial reporting, corporate operations, as well as the transition of the company from private to public in 2018
• Imclone Systems Incorporated (2007-2009): Tax Manager
  

Education

• MS, Taxation, Seton Hall University
• BS, Accounting, Rutgers University – Newark